Kunal Joshi

707 POSTS
Meet Kunal, our insightful writer and manager for the Machine Learning category. Kunal's expertise in machine learning algorithms and applications allows him to provide a deep understanding of this dynamic field. Through his articles, he explores the latest trends, algorithms, and real-world applications of machine learning, making it accessible to all.

Exclusive articles:

Machine Learning Algorithm Predicts Solana Price for July 1, 2023

Bakkt delists popular altcoins amid regulatory challenges in the US. Investors ponder SOL's potential value. Will it be worth $15.84 by July 2023? #crypto #regulation #SOL

Jamia Announces Three-Week Training Program on AI and Machine Learning

Take a short-term training program on AI and ML at Jamia Milia Islamia in India. Open for UG, PG, and PhD scholars and faculty with a math background. Online and offline classes with industry practitioners as teachers. Limited seats available. Register now!

Broadridge’s Machine Learning Technology Secures Patent to Improve Securities Based Lending

Broadridge Financial Solutions has received a patent for its machine learning tech that enhances securities-based lending. This tech provides valuable insights for wealth management firms to deepen relationships with high-value clients and increase productivity.

Get 97% Accurate Hit Song Predictions with Machine Learning in Neuroscience-Based Music Industry

Discover a revolutionary approach to predicting hit songs with 97% accuracy in the music industry, utilizing neuroscience and machine learning. This breakthrough can change the landscape of music composition, production, and performance.

Budapest’s Turbine raises €5.5 million to uncover novel cancer therapies with cell simulation and machine learning

Turbine, a Hungarian biopharma R&D company, secures $6.7m cash injection for its innovative machine learning platform, aimed at identifying new cancer treatments. Following significant €20m investment, Turbine also appoints four independent directors to its board. Supported by the likes of Bayer and MSD, the company aims to advance its internal pipeline of programs, with multiple in vivo validated therapy assets already associated with patients in high unmet need.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img